Bray Capital Advisors
- SEC CIK
- 0001631738
- Latest filing
- Feb 3, 2025
IOVA holding history
Iovance Biotherapeutics, Inc. in every 13F filed by Bray Capital Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
IOVA overviewAll 13F holders of IOVAFull Q4 2024 holdings
- Shares (Q4 2024)
- 43,290
- Value
- $320.3K
- % of portfolio
- 0.1%
- Quarters held
- 1
- Since Q4 2024